CLINSQUARE: CLINICAL RESEARCH COURSES
Saturday, April 19, 2025
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home2020

Yearly Archives: 2020

Tobacco Product Use Down Among Youths in 2020

admin - 0
December 17, 2020: "A report out today from the CDC, in collaboration with the FDA, found that current tobacco product use declined among U.S....

Gilead’s CAR T therapy Tecartus authorised in EU for MCL

admin - 0
December 16, 2020: "Kite, a Gilead Company announced that the European Commission has granted conditional marketing authorization for Tecartus™ (autologous, anti-CD19-transduced CD3+ cells; formerly...

EUSA Pharma launches phase III COVID-19 study for siltuximab

admin - 0
December 17, 2020: "EUSA Pharma, a global biopharmaceutical company, announced today that the first patient has been enrolled in the SILtuximab in Viral ARDS...

Novartis iptacopan receives FDA Breakthrough Therapy Designation for PNH

admin - 0
Novartis investigational oral therapy iptacopan (LNP023) receives FDA Breakthrough Therapy Designation for PNH and Rare Pediatric Disease Designation for C3G December 16, 2020: Novartis announced...

WHO guildlines: Monitoring childbirth in a new era for maternal health

admin - 0
December 15, 2020: "WHO and HRP launch the Labour Care Guide to improve every woman’s experience of childbirth, and to help ensure the health...

Imfinzi recommended for approval in the EU by CHMP

admin - 0
December 15, 2020: AstraZeneca's Imfinzi (durvalumab) has been recommended for marketing authorisation in the EU for an additional dosing option, 1,500mg fixed dose every four weeks,...

Sanofi renews partnership with the WHO to fight Neglected Tropical Diseases

admin - 0
December 15, 2020: "Sanofi has signed on December 10th a renewed partnership agreement with the World Health Organization (WHO), consolidating a 20-year collaboration to fight...

RDIF confirms Sputnik V COVID vaccine’s efficacy

admin - 0
The Sputnik V vaccine’s efficacy is confirmed at 91.4% based on data analysis of the final control point of clinical trials December 14, 2020 – The...

Novartis provides update on RUXCOVID study for hospitalized patients with COVID-19

admin - 0
December 14, 2020: Novartis announced that the Phase III RUXCOVID study evaluating ruxolitinib on top of standard of care (SoC) therapy compared to SoC...

Trixeo Aerosphere approved in the EU for maintenance treatment of COPD

admin - 0
 December 14, 2020: "AstraZeneca’s Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) has been approved in the EU for maintenance treatment in adult patients with moderate to severe chronic...

Pfizer and BioNTech Provide Data from German Phase 1/2 Study

admin - 0
December 14, 2020: "Pfizer and BioNTech announced additional data on neutralizing antibody and T cell responses from the Phase 1/2 trial with BNT162b2 conducted...

EU approved Novartis Leqvio®for the treatment of hypercholesterolemia

admin - 0
December 11, 2020: "Novartis announced that the EC has approved Leqvio®* (inclisiran) for the treatment of adults with hypercholesterolemia or mixed dyslipidemia. This approval is based on the...
1234...65Page 3 of 65
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved